Back to Journals » Hepatic Medicine: Evidence and Research » Volume 1 » default
ESCI
Impact Factor
Hepatic Medicine: Evidence and Research
ISSN: 1179-1535
- View all (191)
- Volume 16, 2024 (6)
- Volume 15, 2023 (22)
- Volume 14, 2022 (13)
- Volume 13, 2021 (16)
- Volume 12, 2020 (16)
- Volume 11, 2019 (16)
- Volume 10, 2018 (13)
- Volume 9, 2017 (10)
- Volume 8, 2016 (15)
- Volume 7, 2015 (8)
- Volume 6, 2014 (12)
- Volume 5, 2013 (7)
- Volume 4, 2012 (7)
- Volume 3, 2011 (14)
- Volume 2, 2010 (14)
- Volume 1, 2009 (2)
Archive: Volume 1, 2009
Original Research
Weekly cisplatin may reverse liver dysfunction and jaundice caused by diffuse liver metastases of solid tumors
M Gabrovska, F Geurs, S Ponette, et al
Hepatic Medicine: Evidence and Research 2009, 1:9-12
Published Date: 30 October 2009
Original Research
A high prevalence of extreme hyperferritinemia in acute hepatitis patients
Kazuhiro Kotoh, Akihiro Ueda, Masatake Tanaka, et al.
Hepatic Medicine: Evidence and Research 2009, 1:1-7
Published Date: 14 September 2009